reserved.
The classical definition of lymphohematopoietic stem cells (LHSC), the most primitive progenitors of all blood cells, requires that they have the capacity for self-renewal and for the long-term production of all blood cell lineages. However, other characteristics of LHSC have been debated. Our previous data suggested that mouse LHSC are very slowly proliferating cells that generate delayed multilineage engraftment, while "radioprotection" (rapid engraftment that will prevent early death from radiationinduced marrow aplasia) results from more committed progenitors. Alternatively, some groups have reported that mouse LHSC are responsible for both radioprotection and long-term repopulation of all blood cell lineages. A possible explanation for this difference is that cells with the capacity for long-term production of all blood cell lineages are biologically heterogeneous. We now show that HE PHENOTYPE AND function of lymphohematopoietic stem cells (LHSC), the most primitive progenitors of all blood cells with the capacity for self-renewal and the long-term production of all blood cell lineages, remain controversial.' Some groups have reported that mouse LHSC are responsible for both "radioprotection" (rapid engraftment that will prevent early death from radiation-induced marrow aplasia) and long-term repopulation of all blood cell These LHSC are also enriched for day 12 spleen colony-forming units (CFU-S).2,3 Alternatively, we and others have suggested that LHSC are slowly proliferating cells that generate delayed multilineage engraftment, whereas radioprotection results from more committed progenitor~.~.~ Moreover, we found that LHSC could be separated from committed progenitors, including day 12 CFU-S, on the basis of their small size by counterflow centrifugal elutriation (CCE). 4 We believe that the most likely reason for this difference is that cells with the capacity for the longterm production of all blood cell lineages are biologically heterogeneous. We further identified and purified LHSC by their lack of expression of antigens characteristic of mature blood cell lineages and their high expression of aldehyde dehydrogenase, in addition to their small size. LHSC were then characterized functionally and by their expression of antigens that have been reported to mark LHSC.
T MATERIALS AND METHODS

Animals.
B6D2Fl mice (National Cancer Institute, Frederick, MD), 6 to 12 weeks of age, were used for all the studies. Female B6D2Fl mice were used as transplant recipients and were housed in sterile microisolator cages. They were fed acidified water and sterilized lab chow ad libitum. Bone marrow (BM) from male B6D2F, mice was used to isolate putative LHSC.
Isolation of mouse LHSC. For each isolation experiment, 8 to 10 male mice were killed by cervical dislocation, and the hind legs were removed. BM was flushed from the medullary cavities of the femurs and tibias using medium and a 25-gauge needle. Single-cell suspensions were produced by repeated passage through the needle. CCE was performed using a Beckman J-6M centrifuge with a E-6B elutriator rotor and a standard chamber (Beckman Instruments, Palo Alto, CA). A master-flex peristaltic pump (Cole Palmer, ChiBlood, Vol 88, No 2 (July 15). 1996: pp 487-491 10 LHSC can generate all blood cell lineages for the lifetime of the animal. However, these cells lacked radioprotection and spleen colony-forming activity. LHSC were identified and isolated by their small size, their lack of expression of antigens characteristic of mature blood cell lineages, and their high expression of aldehyde dehydrogenase. In addition, these cells were found t o express undetectable or low levels of many antigens presumed t o mark LHSC, including Thy-l, Ly-GA/E (Sca-l), c-kit, and CD34. There appears t o be at least two classes of LHSC with the capacity for long-term production of all blood cell lineages: one that generates both radioprotection and long-term engraftment and one that produces delayed but durable engraftment. Our data suggest that this latter class may represent a very primitive class of LHSC.
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cago, IL) equipped with a potentiometer provided precisely metered flow of medium. Male BM cells (=5 X 10') were loaded into the chamber at a flow rate of 15 mL/min and a rotor speed of 1,260g. The cells were eluted by changing flow rates and keeping the rotor speed constant, collecting about 300 mL at each flow rate! BM cells that lack expression of antigens characteristic of mature blood cell lineages ( h -) were initially isolated by direct immune adherence (~a n n i n g )~ using 60-mm polystyrene Petri dishes adsorbed with a cocktail of 60 pg each of rat-antimouse AA4. For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From cells from the CCE large cell or "Rotor Off" (RO) fraction, those remaining in the chamber after eluting the smaller cells at 33 mL/ min; and transplanted via the tail vein into marrow-ablated female B6D2Fl mice. Marrow ablation was achieved with 1,150 cGy of total body irradiation (TBI) and 0.2 mg of dimethyl myleran (DMM) injected intraperitoneally 24 hours before the TBI. Residual host LHSC that survive marrow ablation compete in long-term engraftment with donor stem cells, especially when small numbers are transplanted; the addition of DMM to TBI enhances suppression of host LHSC.' Granulocyte-macrophage colony-forming units (CFU-GM) and CFU-S were assayed as previously described?." Briefly, the CFU-GM cultures contained 30% fetal calf serum, 1% bovine serum albumin, molL 2-mercaptoethanol, and 10% Wehi-conditioned medium as a source of colony-stimulating factor.
Assessment of engraftment by fluorescence in situ hybridization (FISH) for the Y chromosome. Peripheral blood (PB) was obtained by retro-orbital sinus puncture with a heparinized microhematocrit tube to assess engraftment. For determination of lineage engraftment, mice were killed by cervical dislocation. CFU-GM colonies were cultured from the BM, plucked, and pooled (about 500 to 2,000 colonies per mouse) to quantitate myeloid engraftment. B cells were recovered by panning plastic-nonadherent spleen cells (IO' cells/ mL) treated with anti-B220 MoAb and placed in anti-rat IgM-coated Petri dishes for 45 minutes at 4°C. Unbound cells were removed by gentle aspiration; the adherent B220' B cells were obtained by vigorous pipetting. T cells (thymocytes) were obtained by gently dissociating the thymus through a 60-pm mesh screen.
FISH for Y chromosome was performed using modifications of our previously described technique.'' A mouse Y-specific probe for interphase FISH analysis was constructed by microdissection and subsequent polymerase chain reaction (PCR) amplification and biotinylation. Five copies of the Y chromosome q-arm were scraped from a G-banded standard chromosome preparation of male mouse splenocytes and amplified by PCR" using a degenerate primer.' '
The probe was biotinylated by including biotin-dUTP at 20 pmol/ L in a secondary PCR reaction, precipitated with mouse Cot-1 DNA (Life Technologies, Gaithersburg, MD), and used at approximately 200 ng/30 pL hybridization mix (50% formamide, 10% dextran sulfate, 2X standard saline citrate phosphate [SSCP; 0.15 mol/L NaCI, 0.015 mol/L Na citrate, 0.02 mol/L Na,H,POJ) for FISH. Every experiment included a standard curve of known mixtures of male and female cells; the percent male varied by only t 1% on samples of 100% male cells, and false positives (signal on 100% female cells) were never seen. This probe is a significant improvement over our previous method" because the signal is larger and more distinct, the sensitivity and specificity are improved, and there is no requirement for proteinase K treatment of the slides before FISH. The percent male cells (mean t SEM) results include all the assayed animals. Comparison of long-term engraftment at different times after transplant was performed by analysis of variance (AN-OVA).
Flow cytometry for expression of Thy1 and Ly-6A/E (Sca-1).
After isolation, cells were allowed to rest at room temperature for I hour. A single-cell suspension of thymocytes, as a positive control for Thy-I expression, was obtained as described above. The CCE large cell (RO) fraction was the positive control for Ly-6NE expression. The cells were incubated with gentle agitation for 30 minutes at 4°C with either 1 pg of fluorescein (FITC)-conjugated anti-CD90 (Thy-1.2) or 2 pg FITC-conjugated a n t i -L y 6 -a (PharMingen). FITC-conjugated rat IgG2. K control antibody (PharMingen) served as a negative control. After the incubations with the antibodies, the cells were washed and resuspended. Antibody fluorescence intensity was measured on a FACScan flow cytometer (Becton Dickinson, Palo Alto, CA). The results reported in the text are the mean t SEM of at least five experiments.
Reverse transcriptase (RT)-PCR for expression of c-kit or CD34. We used our previously described pr~cedure'~.'' with minor moditications. Total RNA was prepared using the REX total RNA Extraction Kit (USB, Cleveland, OH). To eliminate DNA contamination, the RNA was treated with DNAase I (FPLC pure; Pharmacia, Alameda, CA). First-strand DNA was synthesized with 300 U Moloney Murine Leukemia Virus RT (Gibco BRL, Gaithersburg, MD) using 2-ng random hexanucleotides (Pharmacia) as primers" in the presence of 4 U RNasin (Promega, Madison, WI). The cDNA product was divided for experimental (c-kit or CD34) or control (mouse pactin) PCR reactions. The sequences of the CD34 primers'" and the mouse @-actin primers'"'' have been previously published. The sequences of the mouse c-kit primers arela: 5' sense (1-24) (S'-GAGCTCAGAGTCTAGCGCAGCAC-3') and 3' antisense (739-7 16) (5'-TTTTATGGTGCACACCACCGTAAA-3'). A Coy tempcycler (Model 50; Coy Laboratory Products Inc, Grass Lake, MI) was used with the following program: 5 minutes at 95°C; 35 cycles at 55°C for I minute, 72°C for I minute, 95°C for 1 minute, and one final 72°C extension for S minutes. The amplified products were analyzed by electrophoresis and staining by ethidium bromide. To ensure specificity of RT-PCR for c-kit and CD34 beyond mobility of the product on the gel, the products were transferred and hybridized with either a '*P-labeled c-kit-specific probe (5'-CAATGG-CCTCACGAGTTCTA-3')'8 or a CD34 exon 3-specific probe (S'-
ACATCACCCACCGAGCCATA-3' ).Ih
RESULTS
We previously showed that small mouse BM cells isolated by CCE at a flow rate of 25 mL/min (FR25) are enriched for LHSC that produce delayed multilineage engraftment without radiopr~tection.~ The FR25 cells represented 20% 5 5% of the whole marrow. Marrow cells that lack expression of antigens present on mature blood cell lineages (lin ) are also enriched for LHSC.' AA4.1, an antigen that is expressed by most mouse hematopoietic progenitors and B cells," also was found to be expressed by LHSC from mouse fetal liver2" and 5-fluorouracil-treated adult BM." However, we found that only the FR25 lin-BM cells that were AA4.1 (0.3 2 0.1% of whole marrow) produced long-term engraftment, whereas the small AA4.l+lin-cells were unable to produce long-term engraftment (data not shown), as others have also reported.22 21 Indirect evidence suggests that LHSC express high levels of ALDH,24 25 an enzyme responsible for the conversion of vitamin A to its active metabolite retinoic acid2"' and for cellular resistance to cyclophosphamide.** We further enriched for LHSC by isolating small AA4.1-lin-cells that highly expressed ALDH, as we previously described.' The FR25 AA4.1-lin-ALDH+ cells were 0.005% 5 0.001% of the whole marrow, allowing 1 to 2 X lo4 of these cells to be recovered in one experiment using 8 to 10 mice. For transplantation studies, these cells were combined with a distinguishable source of cells that provide radioprotection: the CCE large cell (RO) fraction that is enriched for committed progenitors while depleted of LHSC." When transplanted into marrow-ablated female B6D2FI mice (20 mice from four separate experiments) with 2 x lo4 female CCE RO BM cells: 10 male FR25 AA4.1-lin-ALDH' BM cells were able to generate most of the PB cells present in the mice for up to 15 months (Fig 1) . Only 4 of 20 mice died; there were 2 early deaths (at 21 and 28 days after BMT) and 2 mice use only. died late (at 8 and 9 months) after BM transplantion (BMT) of unknown causes. The engraftment from the 10 small AA4.1-lin-ALDH+ BM cells was durable (Fig 1) ; the fraction of PB cells derived from these cells at 4, 9, and 15 months after BMT (92% 2 3%, 83% 2 5%, and 68% t lo%, respectively) was not significantly different (P = .15, ANOVA). Moreover, all blood cell lineages (myeloid, B cell, T cell) were derived from the 10 small AA4.1-lin-ALDHf cells ( mice that survived were completely repopulated with female cells at 180 days after BMT.
Despite being able to generate all blood cell lineages for the lifetime of the animal, the small AA4.1-lin-ALDH+ BM cells were unable to provide radioprotection. All mice (16 of 16 from three separate experiments) transplanted with 1,000 FR25 AA4.1-lin-ALDH' cells, but no CCE RO cells to provide initial engraftment, died 15 t 0.5 days after BMT of BM aplasia (Table 1) . Moreover, mice receiving transplants of 1 X lo4 small AA4.1-lin-ALDH+ marrow cells (and no CCE RO cells) also died of aplasia (2 experiments). The small AA4.1-lin-ALDH' marrow cells contained almost no CFU-GM or the more primitive day 12 CFU-S (Table l) , which some groups have found to be inseparable from LHSC.'*3 There were only a total of two CFU-GM colonies in the 16 plates (1,000 FR25 AA4.1-lin-ALDH' cells cultured per plate) from four separate experiments. Similarly, only one spleen colony was observed in 12 mice (from three separate experiments) injected with 1,000 FR25 AA4.1 -lin-ALDH+ cells per mouse.
The small AA4. 1-lin-ALDH' cells were also capable of in vivo self-renewal as assayed by serial BMT.' BM was obtained from four mice that had been transplanted with 10 FR25 AA4.1-lin-ALDH+ BM cells (2 mice were 9 months after BMT and 2 from a separate experiment were 15 months after BMT), and lo6 cells were transplanted into 4 marrowablated secondary female recipients for each primary recipient. Of the 16 secondary recipients, 14 survived 4 months and 10 are alive 8 months after BMT with 31% t 8% and 22% t 5% of their PB cells at 4 months and 8 months, Ly-6AE (Sca-1 p 3 kit,^,'* and CD34,30 have been found to be expressed on cells with the capacity to generate both radioprotection and long-term engraftment. Because the small AA4.1 -lin-ALDH+ BM cells produced only delayed engraftment, we examined the expression of these other antigens on these cells. Thy-1 could not be detected on these cells by flow cytometry (Fig 2A) . Similarly, c-kit expression could not be detected by flow cytometry with anti-c-kit MoAb (data not shown) or by RT-PCR for mRNA expression (Fig 3) . In addition, the c-kit RT-PCR results were confirmed with multiple other sets of primers (data not shown). Ly-6AE was expressed on 7.2% t 2.5% of the small AA4.1-lin-ALDH+ BM cells by flow cytometry (Fig  2B) . Although CD34 expression was detectable in the small AA4.1-lin-ALDH' BM cells by RT-PCR, the levels were lower than those seen in the CCE large cell fraction (Fig 3) that is enriched for less primitive hematopoietic progenitors (ie, CFU-GM and CFU-S).4 DAAA staining did not influence antigen expression; the FR25 AA4.1-lin-cells (not sorted by ALDH expression) displayed similar low-level expression of Ly-6A/E, and c-kit expression was undetectable by RT-PCR.3' use only. not be specific for the most primitive progenitor of blood cells. These criteria for LHSC appear to be fulfilled by at least two classes of cells: one that generates both radioprotection and long-term engraftment (and expresses most antigens presumed to mark LHSC),'.3 and one that produces delayed but durable engraftment (and expresses undetectable or low levels of AA4. I , Thy-I , Ly-6A/E, c-kit, and CD34). Some antigens (eg, Thy-I ," Ly-6A/E3') have been shown to be expressed by LHSC from some normal strains of mice but not other strains. Although mouse strain variability may explain some of the phenotypic differences of LHSC, it probably does not explain the functional differences. Further, antigens that are not invariant characteristics of LHSC from all normal mouse strains are unlikely to be biologically essential for LHSC function.
Identifying the most primitive LHSC with "unlimited" proliferative potential is essential if they are to be used in clinical transplantation, especially as treatment of inherited diseases such as the hemoglobinopathies. The transplantation of LHSC with limited proliferative and self-renewal potential may result in late donor graft failure, perhaps even years after BMT. It is possible that late donor graft failure may not be critical in the setting of a malignancy, where BMT is primarily a rescue procedure for marrow-ablative doses of cytotoxic therapy aimed at the malignancy. Rapid, early engraftment is the primary goal of BMT for malignancy so that the complications of aplasia can be averted. Most BMT preparative regimens do not appear to be truly marrow-ablative, as shown by the frequent occurrence of at least partial host hematopoiesis after T-cell-depleted allogeneic BMT. Therefore, late donor stem cell failure after BMT for a malignancy would be of no significance if residual normal host hematopoiesis returned. However, in the setting of an inherited disease, eventual graft failure resulting from the transplantation of LHSC with limited proliferative and self-renewal potential would lead to resurgence of an abnormal genetic phenotype even if host hematopoiesis returned.
Engraftment of all blood cell lineages arising from limiting numbers of LHSC that also are capable of radioprotection and producing day 12 CFU-S appears to significantly decrease with time after primary BMT, and particularly after serial BMT.'. 
